ArticleACS chemical biology2026
Enzymatic Bromination of Native Peptides for Late-Stage Structural Diversification via Suzuki-Miyaura Coupling.
Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
Flavin-dependent halogenases (FDHs) provide a biocatalytic approach for the site-selective halogenation of aromatic compounds, but their use in late-stage functionalization of peptides has remained limited. Here, we show that tryptophan (Trp) 7-halogenase RebH and an engineered variant (4V) originally optimized for larger small-molecule scaffolds can brominate peptidyl-Trp residues across a broad range of sequences and positional contexts. Through extensive analysis of diverse substrate sequences, we define features that enable RebH activity and reveal 4V's expanded sequence tolerance. We applied 4V for enzymatic bromination of diverse bioactive peptide scaffolds, including an antimicrobial peptide, a cell-penetrating peptide, and a G protein-coupled receptor agonist, without the need for sequence modification. These brominated peptides served as substrates for Suzuki-Miyaura coupling, enabling the installation of modifications that conferred new functional properties or tuned the biological activity of these peptides. Our results expand the substrate landscape of FDHs and establish bromination-enabled cross-coupling as a general approach for late-stage diversification of bioactive peptides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.